September 27, 2017
VIA EDGAR
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Mail Stop 4546
Washington, D.C. 20549
Attention: Ms. Ada D. Sarmento, Senior Counsel
Re: | Acceleration Request of MediciNova, Inc. |
Registration Statement on FormS-3, filed September 22, 2017
(FileNo. 333-220593)
Ladies and Gentlemen:
Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, MediciNova, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effectiveness of the above-referenced Registration Statement, to 4:00 p.m., Eastern Time, on Monday, October 2, 2017, or as soon thereafter as practicable.
Thank you for your assistance. If you should have any questions, please contact Kirt Shuldberg of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, at (858)436-8060.
Very truly yours, |
/s/ Yuichi Iwaki |
Yuichi Iwaki |
President and Chief Executive Officer |